Infinity Pharmaceuticals Inc Sustainability Reports
A clinical-stage biopharmaceutical company focused on developing novel small molecule medicines for people with cancer.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 529900A03D1G15M8WM72
FIGI: BBG001SF95L9
5 reports from 2008 to 2018
